Gene101
ADAM8: ADAM metallopeptidase domain 8
Cite this record
ConductScience Library. ADAM8: ADAM metallopeptidase domain 8. Genes, record 101. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/101
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P78325 | Disintegrin and metalloproteinase domain-containing protein 8 | 824 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents100
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260337292 A1 | 2026-10-29 | 91 | P78325 | Espacenet |
| US 12736547 B2 | 2026-09-15 | 32 | P78325 | Espacenet |
| US 20260266850 A1 | 2026-09-10 | 32 | P78325 | Espacenet |
| US 20260201011 A1 | 2026-07-16 | 303 | P78325 | Espacenet |
| US 20260193644 A1 | 2026-07-09 | 20878 | P78325 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 279 | P78325 | Espacenet |
| US 20260139247 A1 | 2026-05-21 | 5379 | P78325 | Espacenet |
| US 20260125700 A1 | 2026-05-07 | 303 | P78325 | Espacenet |
| US 20260125701 A1 | 2026-05-07 | 303 | P78325 | Espacenet |
| US 12540193 B2 | 2026-02-03 | 91 | P78325 | Espacenet |
NIH grants564
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | ADAM8 papers | Newest fiscal year |
|---|---|---|---|
| U19AI070535 | Airway Inflammation and Airway Remodeling in Severe Asthma | 5 | 2025 |
| P30CA060553 | The Robert H. Lurie Comprehensive Cancer Center | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
| P30EY010572 | Ophthalmology Core Facility | 2 | 2025 |
| P50CA221747 | SPORE for Translational Approaches to Brain Cancer | 2 | 2025 |
| R01GM087415 | Roles of the ER Stress Surveillance Pathway During the Cell Cycle | 2 | 2025 |
| R01HD034568 | Prenatal environmental determinants of health in young adulthood: a lifecourse approach | 2 | 2025 |
| T32HL007633 | Integrated Training in Respiratory Research | 2 | 2025 |
| U19AI135964 | Successful Clinical Response In Pneumonia Therapy (SCRIPT) Systems Biology Center | 2 | 2025 |
| U54MD007598 | Center for Accelerating Excellence in Translational Science (AXIS) | 2 | 2025 |
Source NIH's project files
Papers886
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated multiomics reveals a clinically relevant CXCL8-centric protein network in pediatric postinfectious bronchiolitis obliterans. | Respir Res | 2026 | 42806348 | PubTator, text mining | PubMed |
| The NOR-1/SPP1/OPN axis as a driver of abdominal aortic aneurysm. | Transl Res | 2026 | 42790627 | PubTator, text mining | PubMed |
| Adaptation of Non-Invasive Cancer Cells to 3D Collagen I Microenvironment Induces Transcriptional Reprogramming Accompanied by a More Complex RNA Landscape. | Int J Mol Sci | 2026 | 42589561 | PubTator, text mining | PubMed |
| Dysregulated expression of PSGL-1 and ADAM8 in Sjögren's disease: potential contribution to disease pathogenesis. | Front Immunol | 2026 | 42565023 | PubTator, text mining | PubMed |
| Exploring the Toxicological Relationship Between Diisononyl Cyclohexane-1,2-dicarboxylate and Atherosclerosis Through Network Toxicology, Machine Learning, and Multi-Dimensional Bioinformatics. | Int J Mol Sci | 2026 | 42278201 | PubTator, text mining | PubMed |
| Hypoxia-Induced ADAM8+ Macrophages and FAP+ Fibroblasts Form an Extracellular Matrix-Remodeling Niche at the Tumor Boundary in HCC. | Cancer Immunol Res | 2026 | 42127119 | PubTator, text mining | PubMed |
| ADAM8 Deficiency in Macrophages Alleviates Vascular Calcification in Chronic Kidney Disease. | Front Biosci (Landmark Ed) | 2026 | 42052830 | PubTator, text mining | PubMed |
| ADAM8 mediates eosinophil and neutrophil infiltration and tissue remodeling in chronic rhinosinusitis with nasal polyps. | J Allergy Clin Immunol | 2026 | 42031098 | PubTator, text mining | PubMed |
| The Potential of A Disintegrin and Metalloproteinase (ADAM) Proteins as Clinically Relevant Biomarkers in Colorectal Cancer: A Comprehensive Analysis. | Cancers (Basel) | 2026 | 41976350 | PubTator, text mining | PubMed |
| ACT001 synergizes with temozolomide-based chemoradiotherapy to cure refractory glioblastoma by targeting TNF-CXCL10-CD8+ T-cell immunity. | Front Pharmacol | 2026 | 41769685 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/101
GET https://conductscience.org/api/genes/v1/101/patents?page=2